RTGN — RetinalGenix Technologies Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for RetinalGenix Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.806 | -2.08 | -2.18 | -3.91 | -2.09 |
Depreciation | |||||
Non-Cash Items | 0.644 | 0.578 | 0.856 | 3.48 | 1.33 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.005 | 0.077 | 0.156 | 0.23 | 0.413 |
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.157 | -1.42 | -1.17 | -0.199 | -0.348 |
Capital Expenditures | — | — | — | -0 | 0 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | — | — | — | -0 | 0 |
Financing Cash Flow Items | 0.025 | -0.025 | 0 | 0.109 | 0.348 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.211 | 1.37 | 1.17 | 0.195 | 0.348 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.054 | -0.052 | 0.003 | -0.005 | -0 |